Harding Loevner’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.6M Sell
35,610
-26,365
-43% -$14.2M 0.19% 51
2026
Q2
$31.6M Sell
61,975
-18,455
-23% -$10.6M 0.3% 57
2026
Q1
$54.9M Sell
80,430
-9,384
-10% -$6.49M 0.56% 54
2025
Q4
$51.2M Sell
89,814
-15,697
-15% -$9.11M 0.45% 53
2025
Q3
$64.3M Sell
105,511
-45,696
-30% -$25.9M 0.47% 53
2025
Q2
$75.6M Buy
151,207
+2,829
+2% +$1.39M 0.51% 53
2025
Q1
$76M Sell
148,378
-30,291
-17% -$14.5M 0.58% 48
2024
Q4
$83.8M Sell
178,669
-37,417
-17% -$18.8M 0.57% 47
2024
Q3
$114M Sell
216,086
-4,243
-2% -$2.08M 0.66% 47
2024
Q2
$96.1M Buy
220,329
+18,368
+9% +$8.39M 0.53% 53
2024
Q1
$96.7M Sell
201,961
-23,319
-10% -$10.7M 0.6% 51
2023
Q4
$105M Sell
225,280
-2,209
-1% -$1.04M 0.59% 55
2023
Q3
$100M Sell
227,489
-31,694
-12% -$13.9M 0.66% 53
2023
Q2
$118M Sell
259,183
-2,257
-0.9% -$1.02M 0.69% 51
2023
Q1
$121M Buy
+261,440
New +$121M 0.69% 53

Other funds holding NOC

Harding Loevner's NOC Position: Q3 2026 in Review

Harding Loevner reduced its Northrop Grumman (NOC) stake by 43% in Q3 2026, selling an estimated $14.2M and leaving 35,610 shares worth $17.6M. The position accounts for 0.19% of the portfolio, ranked #51.

Harding Loevner first reported a position in NOC in Q1 2023 and has held it in 15 quarters since. The position peaked at $121M in Q1 2023. 1,788 funds tracked by Wall St. Rank hold NOC as of Q3 2026.

  • Harding Loevner held 35,610 shares of Northrop Grumman worth $17.6M as of Q3 2026.
  • Harding Loevner sold 26,365 Northrop Grumman shares in Q3 2026, an estimated $14.2M.
  • Northrop Grumman made up 0.19% of Harding Loevner's portfolio in Q3 2026, its #51 holding.
  • Harding Loevner first reported a position in Northrop Grumman in Q1 2023 and has held it in 15 quarters since.
  • Harding Loevner's Northrop Grumman position peaked at $121M in Q1 2023.
  • 1,788 funds tracked by Wall St. Rank held Northrop Grumman as of Q3 2026.

Based on Harding Loevner's 13F filing for Q3 2026, filed 16 Nov 2026.